Sanofi-Aventis United States, LLC v. Lines

Decision Date06 December 2017
Docket NumberNo. 16-3668,16-3668
PartiesSANOFI-AVENTIS U.S., LLC; MCKESSON CORPORATION; AXA CORPORATE SOLUTIONS ASSURANCE; CARRAIG INSURANCE LIMITED v. GREAT AMERICAN LINES, INC.; M.V.P. LEASING, INC.; DAVID J. RIEGER, JR.; PILOT TRAVEL CENTERS LLC, t/a PILOT FLYING J v. PILOT TRAVEL CENTERS LLC, Third-Party Plaintiff v. AMED REY PARRA; ABIMAEL FUENTE; LUIS ANDRES FAIFE-RUIZ; DAVID TOPAZ; JOHN DOES 1-5, Third-Party Defendants AXA Corporate Solutions Assurance, Appellant
CourtU.S. Court of Appeals — Third Circuit

NOT PRECEDENTIAL

On Appeal from the United States District Court for the District of New Jersey

(D.C. Civ. Action No. 3-10-cv-02023)

District Judge: Hon. Michael A. Shipp Before: CHAGARES, GREENAWAY, JR., and VANASKIE, Circuit Judges

James P. Krauzlis, Esq. [ARGUED]

Casey & Barnett, LLC

305 Broadway Suite 1202

New York, NY 10007

George N. Styliades, Esq.

Law Offices of George N. Styliades

214 West Main Street, Suite 105

Moorestown, NJ 08057

Counsel for Appellant

Jeffrey D. Cohen, Esq. [ARGUED]

Paul D. Keenan, Esq.

Eric C. Palombo, Esq.

Keenan Cohen & Merrick

125 Coulter Avenue

Suite 1000

Ardmore, PA 19003

Counsel for Appellees Great American Lines, Inc. and MVP Leasing, Inc.

Matthew N. Fiorovanti, Esq. [ARGUED]

Giordano Halleran & Ciesla

125 Half Mile Road, Suite 300

Red Bank, NJ 07701

Counsel for Appellee Pilot Travel Centers, LLC

OPINION*

VANASKIE, Circuit Judge.

This appeal concerns a dispute over liability for the theft of a shipment of pharmaceuticals (the "Freight") while it was in transit from the manufacturer, Sanofi-Aventis U.S., LLC, to the distributor, McKesson Corporation. McKesson's insurer, Appellant AXA Corporate Solutions Assurance, reimbursed McKesson for the loss and then filed a complaint, as McKesson's subrogee, against the trucking companies involved in the shipping—Appellees Great American Lines, Inc. ("GAL") and M.V.P. Leasing, Inc. ("MVP"), as well as the truck stop from which the Freight was stolen, Appellee Pilot Transportation Centers ("Pilot"). Against both GAL and MVP, AXA brought a claim for breach of contract and a claim under the Carmack Amendment, which imposes strict liability on motor carriers engaged in the interstate transportation of goods. See 49 U.S.C. § 14706. Against Pilot, AXA brought a claim of negligence.

The District Court ultimately determined that the contract governing shipment of the Freight waived liability under the Carmack Amendment.1 The Court also determined that McKesson was not a party to the shipping contract, and AXA thus could not base its breach of contract claim on that agreement. Finally, the District Court concluded that AXA had not provided sufficient evidence to warrant a jury trial on the question ofwhether allegedly lax security at the Pilot facility was a cause of the theft of the Freight. For the following reasons, we will affirm.2

I.

Shipment of the Freight was made pursuant to an "Authorized Distribution Agreement" ("ADA") between Sanofi and McKesson. Under the terms of the ADA, Sanofi was responsible for arranging transportation, paying the transportation costs, and ensuring that the shipments were covered by comprehensive transit insurance. To fulfill its obligation to arrange for the shipment of the Freight to McKesson, Sanofi entered into a "Transportation Contract and a Quality Assurance Agreement" ("Transportation Contract") with GAL, who then entered into an Independent Contractor Services Agreement with MVP to provide the tractor trailer and driver for the shipment.

Generally, an agreement like the Transportation Contract would be governed by the Carmack Amendment, under which a "motor carrier" providing interstate transportation of goods for hire is "liable to the person entitled to recover under the receipt or bill of lading" for the "actual loss or injury to the property." § 14706(a)(1). The Transportation Contract, however, contains the following waiver of Carmack liability:

Waiver: Pursuant to 49 U.S.C. 14101(b), the parties expressly waive any and all provisions of the ICC Termination Act of 1995, U.S. Code Title 49, Subtitle IV, Part B, and of regulations thereunder [the Carmack Amendment], to theextent that such provisions conflict with the terms of this Contract or the parties' course of performance hereunder.

(App. 564.) The Transportation Contract further states that it "shall be binding upon and inure to the benefit of the parties hereto only." (App. 562.) The parties do not dispute that McKesson was not a party to the Transportation Contract.

Relating to the Freight in question here, Sanofi and GAL also signed a Truck Manifest, a one page document that contained no contractual terms. The Truck Manifest provided details for the delivery of the Freight and listed McKesson as the consignee.

Pursuant to these agreements, David J. Rieger, a truck driver hired by MVP, loaded the Freight at Sanofi's distribution site in Georgia for delivery to McKesson's distribution facility in Tennessee. While en route, Rieger stopped at a Pilot truck stop in Temple, Georgia, where he left the truck in the rear parking lot for about an hour. Upon returning to the parking lot, Rieger found that the truck was gone.

After the theft, AXA and Carraig Insurance Limited reimbursed McKesson for the value of the Freight, approximately $9 million. AXA seeks recovery of this amount from the transportation companies and Pilot.3

Following discovery, the parties filed cross motions for summary judgment. The District Court ultimately determined that the waiver of Carmack Amendment liability in the Transportation Contract was effective; that AXA, as McKesson's subrogee, was not athird-party beneficiary of the Transportation Contract; that AXA abandoned its breach of contract claim against MVP; that AXA failed to establish that MVP had entered into an implied bailment with respect to the Freight;4 and that AXA had not presented sufficient evidence to warrant a jury trial on the question of whether any negligence of Pilot caused the theft of the Freight. AXA filed this timely appeal.

II.

The District Court had jurisdiction under 28 U.S.C. § 1332(a) and our jurisdiction arises under 28 U.S.C. § 1291. "We review an order granting summary judgment de novo, applying the same standard used by the District Court." Azur v. Chase Bank, USA, Nat'l Ass'n, 601 F.3d 212, 216 (3d Cir. 2010) (quoting Nicini v. Morra, 212 F.3d 798, 805 (3d Cir. 2000)). We will affirm a grant of summary judgment where "there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law." Fed. R. Civ. P. 56(a). A fact is material if it "might affect the outcome of the suit under the governing law." Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248 (1986).

III.

AXA argues that the District Court erred in granting summary judgment to GAL and MVP on its Carmack Amendment and breach of contract claims. According to AXA, because McKesson was neither a party to, nor an intended beneficiary of, the Transportation Contract, the Carmack waiver should not apply. AXA also asserts,arguably for the first time on appeal, that it should be permitted to pursue its breach of contract claims under the Truck Manifest. With regard to its negligence claim against Pilot, AXA contends that the District Court erred in granting summary judgment as genuine disputes of material facts remain. We will address each of these arguments in turn.

A.

As noted above, the Carmack Amendment governs liability of truckers and other carriers engaged in the interstate transportation of goods. § 14706. Pursuant to the statute, a "motor carrier" providing interstate transportation of goods for hire is strictly "liable to the person entitled to recover under the receipt or bill of lading" for the "actual loss or injury to the property." § 14706(a)(1).

Despite this expansive reach of the Carmack Amendment, Congress has permitted carriers and shippers to opt out of Carmack's default rules:

If the shipper and carrier, in writing, expressly waive any or all rights and remedies under this part for the transportation covered by the contract, the transportation provided under the contract shall not be subject to the waived rights and remedies and may not be subsequently challenged on the ground that it violates the waived rights and remedies.

§ 14101(b)(1). The effect of a waiver is that "[t]he exclusive remedy for any alleged breach of a contract entered into under this subsection shall be an action in an appropriate State court or United States district court, unless the parties otherwise agree." § 14101(b)(2).

As the District Court correctly concluded, the waiver in the Transportation Contract plainly precludes AXA from pursuing claims under the Carmack Amendment. The statute does not require that any consignee agree for the waiver to be effective. So long as the "shipper," i.e., Sanofi, and the "carrier," i.e., GAL, agree to the waiver, "the transportation provided under the contract shall not be subject to the waived rights and remedies." § 14101(b)(1) (emphasis added). Accordingly, AXA's Carmack Amendment claim is foreclosed by the waiver in the Transportation Contract.

B.

We also agree with the District Court that summary judgment is appropriate for AXA's breach of contract claims against GAL and MVP. On appeal, AXA abandons its argument that it was an intended beneficiary of the Transportation Contract and instead asserts that its claims arise under the Truck Manifest, which identifies McKesson as consignee and was signed by both Sanofi and GAL. Because AXA did not raise this argument in the District Court, it has been waived.

In its Second Amended Complaint, AXA based its contract claims entirely on the Transportation Contract, without mention of the Truck Manifest. In its memorandum in support of its motion for summary judgment, AXA stated that, if the District Court were to find that the Carmack waiver applied, "the exclusive remedy against GAL" would be "for breach of the Transportation Contract."...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT